Showing results (181-190 of 306) with videos related to
Sort By:
Pageof 31
Virology|April 29, 2011
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope proteinJose L Nieto-Torres, Marta L Dediego, Enrique Alvarez, et al.Parasitology International|February 28, 2012
Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania sppInmaculada Ramírez-Macías, Clotilde Marín, Hakima Es-Samti, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2022
Targeting IFN-λ Signaling Promotes Recovery from Central Nervous System AutoimmunitySindhu Manivasagam, Jessica L Williams, Lauren L Vollmer, et al.Annals of Neurology|October 3, 2025
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple SclerosisLaura Ghezzi, Peter Kosa, Mark Greenwood, et al.Frontiers in Neurology|October 19, 2020
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer AcetateJustin M Honce, Kavita V Nair, Brian D Hoyt, et al.Cell Death & Disease|April 8, 2023
Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosisWenbo Zhou, Michael Graner, Petr Paucek, et al.Journal of Natural Products|November 30, 2020
In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent NecrosisRubén Martín-Escolano, Juan J Guardia, Javier Martín-Escolano, et al.Organic & Biomolecular Chemistry|December 5, 2013
The first synthesis of (-)-isoambreinolide, (+)-vitexifolin D and (+)-vitedoin BHanane Bouanou, Rubén Tapia, M José Cano, et al.Journal of Virology|May 9, 2008
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamstersElaine W Lamirande, Marta L DeDiego, Anjeanette Roberts, et al.Journal of the Neurological Sciences|October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-upBrandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.Pageof 31